Hatteras Venture Advisors IV SBIC, LLC → Clearside Biomedical, Inc. CLSDQ

Stake: 40.00% Shares: 313,641 CUSIP: 185063104 Class: Common Stock, $0.001 Par Value

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -18.7%

Passive Schedule 13G filer baseline
Elevated short days-to-cover (18.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 18.07

95,698 shares short · 0.0% vs prior

Post-Filing Returns · since 2024-09-13 on CLSDQ

+1 day

+6.5%

+5 days

+5.7%

+30 days

-3.3%

+60 days

-9.8%

+90 days

-18.7%

+180 days

-29.3%

Anchor price 18.45 on closest trading day on/after 2024-09-13. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Clearside Biomedical, Inc.

Filed	Form	Filer	Stake	Shares
2019-12-04	SC	Hatteras Venture Advisors III, LLC	—	—	view →
2019-07-17	SC	Hatteras Venture Advisors III, LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →